Abstract

The choice of DNA double strand break (DSB) repair pathway is determined at the stage of DSB end resection. Resection was proposed to control the balance between the two major DSB repair pathways, homologous recombination (HR) and non-homologous end joining (NHEJ). Here, we examined the regulation of DSB repair pathway choice at two-ended DSBs following ionizing radiation (IR) in G2 phase of the cell cycle. We found that cells pre-exposed to low-dose IR preferred to undergo HR following challenge IR in G2, whereas NHEJ repair kinetics in G1 were not affected by pre-IR treatment. Consistent with the increase in HR usage, the challenge IR induced Replication protein A (RPA) foci formation and RPA phosphorylation, a marker of resection, were enhanced by pre-IR. However, neither major DNA damage signals nor the status of core NHEJ proteins, which influence the choice of repair pathway, was significantly altered in pre-IR treated cells. Moreover, the increase in usage of HR due to pre-IR exposure was prevented by treatment with ATM inhibitor during the incubation period between pre-IR and challenge IR. Taken together, the results of our study suggest that the ATM-dependent damage response after pre-IR changes the cellular environment, possibly by regulating gene expression or post-transcriptional modifications in a manner that promotes resection.

Highlights

  • Ionizing irradiation (IR) is widely utilized in cancer treatment, and the generation of radiotherapy, including particle therapies, is promising [1]

  • To investigate whether Pre-exposure to low-dose IR (pre-IR) treatment affects the balance of double strand break (DSB) repair-pathway choice between homologous recombination (HR) and non-homologous end joining (NHEJ), we measured the efficiency of repair following pre-IR using chromosomal HR and NHEJ assays in the U2OS and H1299 cell lines, respectively (Fig 1A) [25,26]

  • To confirm that each assay monitored HR or NHEJ as predicted, we examined repair efficiencies in cells depleted for CtIP or BRCA2 using specific siRNAs or treated with a DNA-PKcs inhibitor

Read more

Summary

Introduction

Ionizing irradiation (IR) is widely utilized in cancer treatment, and the generation of radiotherapy, including particle therapies, is promising [1]. Exposure to IR can increase the risk of cancer, the risk associated with low-dose IR is still under debate [2,3]. Radiation-associated cancer risk is an important concern in environments such as outer space, where biological tissue can be exposed to relatively high doses of cosmic radiation.

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call